Steels E, et al. Inflammopharmacology 2019 Jun;27(3):475-85.
Palmitoylethanolamide (PEA) cannot be recommended as a routine therapy for knee osteoarthritis in Australian primary care,
Tag: knee
Oct 11 2019
Palmitoylethanolamide (PEA) as treatment for knee osteoarthritis pain
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1787
Jul 12 2019
Duloxetine as treatment for knee osteoarthritis pain
Osani et al. Korean J Intern Med 2019 Mar 15
Duloxetine (60-120 mg daily) appears to have a small to moderate beneficial effect on knee osteoarthritis pain and function at 3 months, compared to placebo.
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=1782
Jan 28 2011
Glucosamine and/or chondroitin for osteoarthritis
Wandel S, et al. Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis. BMJ 2010;341:c4675
Glucosamine, chondroitin and their combination do not improve pain or reduce joint space loss in osteoarthritis of the hip or knee.
Permanent link to this article: https://evidencebasedmedicine.com.au/?p=270
Recent Comments